Subcellular compartmentalization of proteolytic enzymes in brain regions and the effects of chronic β-amyloid treatment

Brain Research

Volumn 1369, Issue , 2011, Pages 184-193

  Kosenko, Elena ^a   Poghosyan, Armenuhi ^b   Kaminsky, Yury ^a  

^a INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

^b RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

Author keywords

Amyloid peptide; Brain regions; Proteases; Subcellular structures

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; BETA GALACTOSIDASE; CALPAIN 1; CALPAIN 2; CASPASE 3; CASPASE 9; CATHEPSIN B; CATHEPSIN D; PROTEINASE;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL COMPARTMENTALIZATION; CELL FRACTIONATION; CEREBELLUM; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; HIPPOCAMPUS; INTRACELLULAR MEMBRANE; LYSOSOME; MALE; MITOCHONDRION; NEOCORTEX; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CELL NUCLEUS; CYTOSOL; LYSOSOMES; MALE; MITOCHONDRIA; PEPTIDE HYDROLASES; RATS; RATS, WISTAR;

RATTUS;

EID: 78651078114     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.10.078     Document Type: Article

References (63)

1. E. Adamec, P. Mohan, J.P. Vonsattel, and R.A. Nixon Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2 Acta Neuropathol. (Berl) 104 2002 92 104
2. A.M. Aleardi, G. Benard, O. Augereau, M. Madat, J.C. Talbot, J.P. Mazat, T. Letellier, J. Dachary-Prigent, G.C. Solaini, and R. Rossignol Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release J. Bioenerg. Biomembr. 37 2005 207 225
3. G. Aliev, M.E. Obrenovich, V.P. Reddy, J.C. Shenk, P.I. Moreira, A. Nunomura, X. Zhu, M.A. Smith, and G. Perry Antioxidant therapy in Alzheimer's disease: theory and practice Mini Rev. Med. Chem. 8 2008 1395 1406
4. J.W. Allen, B.A. Eldadah, X. Huang, S.M. Knoblach, and A.I. Faden Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis J. Neurosci. Res. 65 2001 45 53
5. E.S. Alnemri, D.J. Livingston, D.W. Nicholson, G. Salvesen, N.A. Thornberry, W.W. Wong, and J. Yuan Human ICE/CED-3 protease nomenclature Cell 872 1996 171
6. D. Arrington, T. Van Vleet, and R. Schnellmann Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunction Am. J. Physiol. Cell Physiol. 291 2006 C1159 C1171
7. D.F. Bishop, K.J. Dean, C.C. Sweeley, and R.J. Desnick Purification and characterization of human alpha-galactosidase isozymes: comparison of tissue and plasma forms and evaluation of purification methods Birth Defects Orig. Artic. Ser. 16 1980 17 32
8. B. Boland, and V. Campbell beta-Amyloid (1-40)-induced apoptosis of cultured cortical neurons involves calpain-mediated cleavage of poly-ADP-ribose polymerase Neurobiol. Aging 24 2003 179 186
9. I. Budihardjo, H. Oliver, M. Lutter, X. Luo, and X. Wang Biochemical pathways of caspase activation during apoptosis Annu. Rev. Cell Dev. Biol. 15 1999 269 290
10. M. Chen, and H.L. Fernandez Mu-calpain is functionally required for alpha-processing of Alzheimer's beta-amyloid precursor protein Biochem. Biophys. Res. Commun. 330 2005 714 721
11. C. Emiliani, L. Urbanelli, L. Racanicchi, A. Orlacchio, G. Pelicci, S. Sorbi, G. Bernardi, and A. Orlacchio Up-regulation of glycohydrolases in Alzheimer's disease fibroblasts correlates with Ras activation J. Biol. Chem. 278 2003 38453 38460
12. A. Fifre, I. Sponne, V. Koziel, B. Kriem, F.T. Yen Potin, B.E. Bihain, J.L. Olivier, T. Oster, and T. Pillot Microtubule-associated protein MAP1A, MAP1B, and MAP2 proteolysis during soluble amyloid beta-peptide-induced neuronal apoptosis. Synergistic involvement of calpain and caspase-3 J. Biol. Chem. 281 2006 229 240
13. S.A. Frautschy, D.L. Horn, J.J. Sigel, M.E. Harris-White, J.J. Mendoza, F. Yang, T.C. Saido, and G.M. Cole Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain J. Neurosci. 18 1998 8311 8321
14. J.M. Garland, and C. Rudin Cytochrome c induces caspase-dependent apoptosis in intact hematopoietic cells and overrides apoptosis suppression mediated by bcl-2, growth factor signaling, MAP-kinase-kinase, and malignant change Blood 92 1998 1235 1246
15. D.E. Goll, V.F. Thompson, H. Li, W. Wei, and J. Cong The calpain system Physiol. Rev. 83 2003 731 801
16. Y. Horikawa, N. Oda, N.J. Cox, X. Li, M. Orho-Melander, M. Hara, Y. Hinokio, T.H. Lindner, H. Mashima, P.E. Schwarz, L. del Bosque-Plata, Y. Horikawa, Y. Oda, I. Yoshiuchi, S. Colilla, K.S. Polonsky, S. Wei, P. Concannon, N. Iwasaki, J. Schulze, L.J. Baier, C. Bogardus, L. Groop, E. Boerwinkle, C.L. Hanis, and G.I. Bell Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus Nat. Genet. 26 2000 163 175
17. R.U. Jänicke, M.L. Sprengart, M.R. Wati, and A.G. Porter Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis J. Biol. Chem. 273 1998 9357 9360
18. Y. Kaminsky, and E. Kosenko Brain purine metabolism and xanthine dehydrogenase/oxidase conversion in hyperammonemia are under control of NMDA receptors and nitric oxide Brain Res. 1294 2009 193 201
19. Y.G. Kaminsky, E.A. Kosenko, E.A. Mugantseva, I.Y. Podolski, C. Montoliu, and V. Felipo DNA fragmentation, poly(ADP-ribose) polymerase, NAD-synthetase, NAD-glycohydrolase, and p53 protein in nuclei from brain cells and Alzheimer's disease Basic Research for Medicine 2004 Slovo Moscow 15 17 (In Russian)
20. Y.G. Kaminsky, E.A. Kosenko, N.I. Venediktova, V. Felipo, and C. Montoliu Apoptotic markers in the mitochondria, cytosol, and nuclei of brain cells during ammonia toxicity Neurochem. J. 1 2007 78 85
21. H. Kirschke, A.J. Barrett, and N.D. Rawlings Proteinases 1: lysosomal cysteine proteinases Protein Profile 2 1995 1581 1643
22. R.M. Kluck, E. Bossy-Wetzel, D.R. Green, and D.D. Newmeyer The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis Science 275 1997 1132 1136
23. E. Kosenko, N. Venediktova, Y. Kaminsky, C. Montoliu, and V. Felipo Preparation and handling of brain mitochondria useful to study uptake and release of calcium Brain Res. Brain Res. Protoc. 7 2001 248 254
24. E. Kosenko, C. Montoliu, G. Giordano, Y. Kaminsky, N. Venediktova, Y. Buryanov, and V. Felipo Acute ammonia intoxication induces an NMDA receptor-mediated increase in poly(ADP-ribose) polymerase level and NAD metabolism in nuclei of rat brain cells J. Neurochem. 89 2004 1101 1110
25. H.J. Lee, H. Sorimachi, S.Y. Jeong, S. Ishiura, and K. Suzuki Molecular cloning and characterization of a novel tissue-specific calpain predominantly expressed in the digestive tract Biol. Chem. 379 1998 175 183
26. P. Li, D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, E.S. Alnemri, and X. Wang Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade Cell 91 1997 479 489
27. X. Liu, C.N. Kim, J. Yang, R. Jemmerson, and X. Wang Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c Cell 86 1996 147 157
28. O.H. Lowry, N.J. Rosenbrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
29. A.V. Maltsev, E.A. Kosenko, N.I. Venediktova, and Y.G. Kaminsky Roles of neuronal pathogenic proteins, glutamate receptors and mitochondria in the development of neurodegenerative diseases Gerontologiya i Geriatriya 2 2003 78 83 (In Russian)
30. M. Manczak, T.S. Anekonda, E. Henson, B.S. Park, J. Quinn, and P.H. Red Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression Hum. Mol. Genet. 15 2006 1437 1449
31. W.R. Markesbery Oxidative stress hypothesis in Alzheimer's disease Free Radic. Biol. Med. 23 1997 134 147
32. J.A. Medin, M. Tudor, R. Simovitch, J.M. Quirk, S. Jacobson, G.J. Murray, and R.O. Brady Correction in trans for Fabry disease: expression, secretion and uptake of alpha-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vector Proc. Natl. Acad. Sci. U. S. A. 93 1996 7917 7922
33. S. Morais Cardoso, R.H. Swerdlow, and C.R. Oliveira Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria Brain Res. 931 2002 117 125
34. P.I. Moreira, S.L. Siedlak, X. Wang, M.S. Santos, C.R. Oliveira, M. Tabaton, A. Nunomura, L.I. Szweda, G. Aliev, M.A. Smith, X. Zhu, and G. Perry Increased autophagic degradation of mitochondria in Alzheimer disease Autophagy 3 2007 614 615
35. 2+-dependent arotease (calpain) and its high-molecular-weight endogenous inhibitor (calpastatin) Adv. Enzyme Regul. 19 1980 407 424
36. R.A. Nixon, K.I. Saito, F. Grynspan, W.R. Griffin, S. Katayama, T. Honda, P.S. Mohan, T.B. Shea, and M. Beermann Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease Ann. N Y Acad. Sci. 747 1994 77 91
37. T. Ohshita, and H. Kido Simple preparation of rat brain lysosomes and their proteolytic properties Anal. Biochem. 230 1995 41 47
38. A. Olariu, K. Yamada, T. Mamiya, V. Hefco, and T. Nabeshima Memory impairment induced by chronic intracerebroventricular infusion of beta-amyloid (1-40) involves downregulation of protein kinase C Brain Res. 957 2002 278 286
39. G. Pan, K. O'Rourke, and V.M. Dixit Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex J. Biol. Chem. 273 1998 5841 5845
40. A. Papassotiropoulos, M. Bagli, A. Kurz, J. Kornhuber, H. Forstl, W. Maier, J. Pauls, N. Lautenschlager, and R. Heun A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease Ann. Neurol. 47 2000 399 403 (Pubitemid 30141856)
41. J.K. Parks, T.S. Smith, P.A. Trimmer, J.P. Bennett, and W.D. Parker Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro J. Neurochem. 76 2001 1050 1056
42. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates - the new coronal set 2004 Academic Press New York
43. B.J. Perrin, and A. Huttenlocher Calpain Int. J. Biochem. Cell Biol. 34 2002 722 725
44. 60 fullerene on amyloid β-peptide fibrillization in vitro and performance of the cognitive task J. Nanosci. Nanotechnol. 7 2007 1479 1485
45. F. Raynaud, and A. Marcilhac Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease FEBS J. 273 2006 3437 3443
46. N.K. Robakis β-Amyloid and amyloid precursor protein: chemistry, molecular biology, and neuropathology R. Terry, R. Kattmann, E. Bicke, Alzheimer's Disease 1994 Raven Press New York 317 326
47. K. Saito, J.S. Elce, J.E. Hamos, and R.A. Nixon Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration Proc. Natl. Acad. Sci. U. S. A. 90 1993 2628 2632
48. S. Sandmann, F. Prenzel, L. Shaw, R. Schauer, and T. Unger Activity profile of calpains I and II in chronically infarcted rat myocardium-influence of the calpain inhibitor CAL 9961 Br. J. Pharmacol. 135 2002 1951 1958
49. M. Shoji, T.E. Golde, J. Ghiso, T.T. Cheung, S. Estus, L.M. Shaffer, X.D. Cai, D.M. McKay, R. Tintner, and B. Frangione Production of the Alzheimer amyloid beta protein by normal proteolytic processing Science 258 1992 126 129
50. R. Siman, J.P. Card, and L.G. Davis Proteolytic processing of beta-amyloid precursor by calpain I J. Neurosci. 10 1990 2400 2411
51. H. Sorimachi, S. Imajoh-Ohmi, Y. Emori, H. Kawasaki, S. Ohno, Y. Minami, and K. Suzuki Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and mu-types. Specific expression of the mRNA in skeletal muscle J. Biol. Chem. 264 1989 20106 20111
52. 2+-binding domain J. Biol. Chem. 268 1993 19476 19482
53. E. Tamagno, P. Bardini, M. Guglielmotto, O. Danni, and M. Tabaton The various aggregation states of β-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression Free Radic. Biol. Med. 41 2006 202 212
54. L. Tillement, L. Lecanu, W. Yao, J. Greeson, and V. Papadopoulos The spirostenol (22R, 25R)-20alpha-spirost-5-en-3beta-yl hexanoate blocks mitochondrial uptake of Abeta in neuronal cells and prevents Abeta-induced impairment of mitochondrial function Steroids 71 2006 725 735
55. 2+ channels: a possible involvement of free radicals J. Neurochem. 68 1997 265 271
56. D. Vaudry, C. Cottet-Rousselle, M. Basille, A. Falluel-Morel, A. Fournier, H. Vaudry, and B.J. Gonzalez Pituitary adenylate cyclase-activating polypeptide inhibits caspase-3 activity but does not protect cerebellar granule neurons against beta-amyloid (25-35)-induced apoptosis Regul. Pept. 123 2004 43 49
57. 2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture J. Neurochem. 62 1994 372 375
58. J. Xu, S. Chen, G. Ku, S.H. Ahmed, J. Xu, H. Chen, and C.Y. Hsu Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation J. Cereb. Blood Flow Metab. 21 2001 702 710
59. K. Yamamoto, and V.T. Marchesi Purification and characterization of acid proteinase from human erythrocyte membranes Biochim. Biophys. Acta 790 1984 208 218
60. S.M. Yatin, M. Aksenova, M. Aksenov, W.R. Markesbery, T. Aulick, and D.A. Butterfield Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses J. Mol. Neurosci. 11 1998 183 197
61. 2+ proteases (calpain I and calpain II) purified concurrently by the same method from rat kidney J. Biol. Chem. 258 1983 8883 8889
62. N. Zamzami, P. Marchetti, M. Castedo, D. Decaudin, A. Macho, T. Hirsch, S.A. Susin, P.X. Petit, B. Mignotte, and G. Kroemer Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death J. Exp. Med. 182 1995 367 377
63. H. Zeng, Q. Chen, and B. Zhao Genistein ameliorates beta-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis Free Radic. Biol. Med. 36 2004 180 188